Cited by 26Renin-Angiotensin System StudiesAngiogenesis and VEGF in CancerEicosanoids and Hypertension Pharmacology

Effects of the renin angiotensin system on vasculogenesis-related progenitor cells

Roks, Anton JM, Rodgers, Kathy, Walther, Thomas·2011·Current Opinion in Pharmacology

Abstract

The current concept is that there are both cells that integrate into the vasculature, true endothelial progenitor cells (EPC), and cells with hematopoietic markers that support neovascularisation. As identification of the EPC is controversial and studies refer cells that might fall into either pools, we will use the term, vasculogenesis-related progenitor cells (VRPC), for this review. VRPC are considered to be an important target for the treatment of cardiovascular diseases (CVD). Angiotensin II is known to be an important player in neovascularisation and the modulation of renin angiotensin system (RAS) is one of the major pharmacotherapeutic strategies for the treatment of CVD. We will review the effects of different components of the RAS on such VRPC under physiological conditions and in CVD. The reviewed research strongly supports a critical role of the RAS in vasculogenesis and vascular regeneration. Therefore, pharmacological intervention on the components of the RAS does not only target directly end-organ remodelling and blood pressure but also influence tissue healing and/or regeneration by influencing specific progenitor cells. Thus, the interrogation of RAS effects on VRPC will be important in the optimisation of RAS intervention or regenerative therapy.

Integrity signals

Registry

Crossref · 10.1016/j.coph.2011.01.002

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Roks, A. J., Rodgers, K., & Walther, T.
Affiliations
  • Erasmus MC (NL)
  • University of Southern California (US)
  • University of Hull (GB)
Corresponding author
Walther, Thomas
Venue
Current Opinion in Pharmacology
Publisher
Elsevier BV
Published
2011-04
Volume
11
Issue
2
Pages
162-174
ISSN
1471-4892 (ISSN-L)
OpenAlex
W2052200425
Cited by
26
References
87
Citations by year
2024: 5 · 2023: 1 · 2022: 2 · 2020: 1 · 2019: 1 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 3
FWCI
0.43
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
renin-angiotensin system, endothelial progenitor cells, angiotensin II, neovascularization, vascular regeneration, cardiovascular disease, regenerative therapy
MeSH terms
Angiotensin-Converting Enzyme Inhibitors, Angiotensins, Animals, Cardiovascular Diseases, Disease Models, Animal, Hematopoiesis, Humans, Renin-Angiotensin System, Stem Cells, Reactive Oxygen Species, Neovascularization, Physiologic, Endothelial Cells, Angiotensin Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review